Febrivac 3-PLUS injekcinė suspensija audinėms
Febrivac 3-PLUS injekcinė suspensija audinėms
Authorised
- Pseudomonas aeruginosa, serotype 7/8, strain EP1, Inactivated
- Pseudomonas aeruginosa, serotype 6, strain EP2, Inactivated
- Pseudomonas aeruginosa, serotype 5, strain EP3, Inactivated
- Clostridium botulinum, type C, toxoid
- Mink enteritis virus, Inactivated
Product identification
Medicine name:
Febrivac 3-PLUS injekcinė suspensija audinėms
Active substance:
- Pseudomonas aeruginosa, serotype 7/8, strain EP1, Inactivated
- Pseudomonas aeruginosa, serotype 6, strain EP2, Inactivated
- Pseudomonas aeruginosa, serotype 5, strain EP3, Inactivated
- Clostridium botulinum, type C, toxoid
- Mink enteritis virus, Inactivated
Target species:
-
Mink
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Pseudomonas aeruginosa, serotype 7/8, strain EP1, Inactivated100000000.00/cells1.00Dose
-
Pseudomonas aeruginosa, serotype 6, strain EP2, Inactivated100000000.00/cells1.00Dose
-
Pseudomonas aeruginosa, serotype 5, strain EP3, Inactivated100000000.00/cells1.00Dose
-
Clostridium botulinum, type C, toxoid0.50/relative unit(s)1.00Dose
-
Mink enteritis virus, Inactivated10000.00/50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI20CL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- IDT Biologika GmbH
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/00/1166/001-003
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 4/02/2025